Exodus Point Capital Management, LP Amphastar Pharmaceuticals, Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 51,315 shares of AMPH stock, worth $2.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
51,315
Previous 54,531
5.9%
Holding current value
$2.4 Million
Previous $2.39 Million
14.24%
% of portfolio
0.01%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.3MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$278 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$125 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$90.9 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$79 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$75.8 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.29B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...